Press Releases
Keyword Search
08.03.21
OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
07.07.21
OpGen Announces Partial Adjournment of Annual Meeting
06.30.21
OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum
06.28.21
OpGen Group Company Ares Genetics Presents R&D Pipeline Updates
06.09.21
OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed
06.09.21
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
06.07.21
OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland
05.13.21
OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
04.29.21
OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time
04.19.21
OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections